Payment overview · 2025
General Payments
$302.41
11 reported records · 4 companies
Healthcare provider profile · identity verified
Robert K Parangi, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · PARAMUS, NJ · NPI 1528131281
Verified facts
What the public records show
CMS Open Payments records show Robert K Parangi, M.D. received $302.41 in general payments during 2025 across 11 reported records.
Braeburn Inc. accounted for 44.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Braeburn Inc. | Unresolved — no canonical attribution shown | $133.51 | 44.1% | 8 | 2025 |
| Intra-Sana Laboratories | Unresolved — no canonical attribution shown | $119.90 | 39.6% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $30.23 | 10.0% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $18.77 | 6.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $302.41 | 11 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $133.51 | 8 | 2025 |
Source payment records
|
|||||
| GLYCATE Normalized: glycate |
Drug | Intra-Sana Laboratories | $119.90 | 1 | 2025 |
Source payment records
|
|||||
| RELTONE 200 MG Normalized: reltone 200 mg |
Drug | Intra-Sana Laboratories | $119.90 | 1 | 2025 |
Source payment records
|
|||||
| RELTONE 400 MG Normalized: reltone 400 mg |
Drug | Intra-Sana Laboratories | $119.90 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN Access System Normalized: watchman access system |
Device | Boston Scientific Corporation | $30.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 395 | 37 |
| Atorvastatin Calcium | Atorvastatin Calcium | 369 | 97 |
| Amlodipine Besylate | Amlodipine Besylate | 241 | 60 |
| Levothyroxine Sodium | Levothyroxine Sodium | 205 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 197 | 44 |
| Oxycodone Hcl | Oxycodone Hcl | 189 | 19 |
| Gabapentin | Gabapentin | 173 | 38 |
| Mirtazapine | Mirtazapine | 173 | 40 |
| Metformin Hcl | Metformin Hcl | 168 | 39 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 166 | 22 |
| Divalproex Sodium | Divalproex Sodium | 162 | 26 |
| Famotidine | Famotidine | 139 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 118 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 23 |
| Lisinopril | Lisinopril | 112 | 23 |
| Januvia | Sitagliptin Phosphate | 110 | 11 |
| Losartan Potassium | Losartan Potassium | 109 | 26 |
| Clonazepam | Clonazepam | 106 | 14 |
| Alprazolam | Alprazolam | 105 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 94 | 20 |
| Sertraline Hcl | Sertraline Hcl | 93 | 16 |
| Simvastatin | Simvastatin | 93 | 18 |
| Pantoprazole Sodium | Pantoprazole Sodium | 91 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 89 | 17 |
| Benztropine Mesylate | Benztropine Mesylate | 88 | suppressed |
| Mupirocin | Mupirocin | 87 | 13 |
| Risperidone | Risperidone | 85 | 14 |
| Furosemide | Furosemide | 84 | 18 |
| Santyl | Collagenase Clostridium Hist. | 81 | 12 |
| Alendronate Sodium | Alendronate Sodium | 79 | 13 |
| Lorazepam | Lorazepam | 77 | suppressed |
| Myrbetriq | Mirabegron | 77 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 76 | 18 |
| Finasteride | Finasteride | 73 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 71 | 16 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 70 | 69 |
| Montelukast Sodium | Montelukast Sodium | 68 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | 14 |
| Carvedilol | Carvedilol | 61 | 17 |
| Silver Sulfadiazine | Silver Sulfadiazine | 60 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 54 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 53 | suppressed |
| Omeprazole | Omeprazole | 53 | 18 |
| Enoxaparin Sodium | Enoxaparin Sodium | 52 | suppressed |
| Levetiracetam | Levetiracetam | 51 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 48 | suppressed |
| Diazepam | Diazepam | 47 | 15 |
| Glimepiride | Glimepiride | 47 | 15 |
| Ezetimibe | Ezetimibe | 46 | 13 |
| Lactulose | Lactulose | 46 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 46 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 15 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 45 | 44 |
| Xarelto | Rivaroxaban | 45 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 44 | 24 |
| Potassium Chloride | Potassium Chloride | 44 | 13 |
| Azithromycin | Azithromycin | 43 | 34 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 43 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | suppressed |
| Olanzapine | Olanzapine | 40 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 39 | suppressed |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Novolog | Insulin Aspart | 38 | suppressed |
| Pregabalin | Pregabalin | 37 | suppressed |
| Tresiba | Insulin Degludec | 37 | suppressed |
| Belbuca | Buprenorphine Hcl | 35 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 35 | 22 |
| Fentanyl | Fentanyl | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 34 | suppressed |
| Prednisone | Prednisone | 33 | suppressed |
| Trulicity | Dulaglutide | 33 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 32 | 17 |
| Latanoprost | Latanoprost | 32 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 32 | 11 |
| Donepezil Hcl | Donepezil Hcl | 31 | suppressed |
| Ibuprofen | Ibuprofen | 31 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 31 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 29 | suppressed |
| Jardiance | Empagliflozin | 29 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 28 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Torsemide | Torsemide | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Aripiprazole | Aripiprazole | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 19 |
| Digoxin | Digoxin | 25 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 25 | suppressed |
| Ozempic | Semaglutide | 25 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 23 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Nystatin | Nystatin | 23 | 14 |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Nifedipine Er | Nifedipine | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Carisoprodol | Carisoprodol | 21 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Risperidone Er | Risperidone Microspheres | 21 | suppressed |
| Endocet | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Allopurinol | Allopurinol | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Silodosin | Silodosin | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 11 |
| Lovastatin | Lovastatin | 18 | suppressed |
| Scopolamine | Scopolamine | 18 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 17 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 17 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 12 |
| Oxycontin | Oxycodone Hcl | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Meloxicam | Meloxicam | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Acetazolamide | Acetazolamide | 14 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 14 | suppressed |
| Celecoxib | Celecoxib | 14 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Lumigan | Bimatoprost | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Loxapine | Loxapine Succinate | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Atenolol | Atenolol | 11 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 11 | suppressed |
| Budesonide Dr | Budesonide | 11 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 11 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 11 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 11 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $302.41 · 11 records | Braeburn Inc. | BRIXADI, GLYCATE, RELTONE 200 MG, RELTONE 400 MG, WATCHMAN Access System | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error